The decline in COVID products as the pandemic has shifted into an endemic phase was to be expected but has shown its impact on the balance sheet of major pharma companies throughout the Q3 earnings season.
Experts discuss how to ‘move the needle’ on COVID-19 vaccine confidence
The Swiss drugmaker, which reported an otherwise upbeat second quarter, allocated a substantial reserve to settle bribery charges stemming from the suit.